China
China approves Eisai’s Fycompa for partial onset epileptic seizures
October 16, 2019Research and Development, Sales and Marketing China, Eisai, Fycompa, epilepsy, pharma
Tokyo-headquartered firm Eisai has announced that its antiepileptic drug (AED) Fycompa (perampanel) has received approval from China’s National Medical Products …
AZ’s Tagrisso secures China approval in first-line advanced lung cancer
September 4, 2019Research and Development, Sales and Marketing AstraZeneca, China, Tagrisso, lung cancer, pharma
AstraZeneca’s Tagrisso (osimertinib) has secured approval in China from the country’s National Medical Products Administration (NMPA) in the first-line treatment …
Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds
August 28, 2019Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma
Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …
Top Ten most popular articles on Pharmafile.com this week
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit
This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …
China urges firms to make generic versions of 34 drugs
June 25, 2019Research and Development China, NHC, generic drugs, generics, patents, pharma
China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …
Three workers killed by explosion at pharma factory in India
June 11, 2019Manufacturing and Production China, India, explosion, manufacturing, pharma
Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …
Top Ten most popular articles on Pharmafile.com this week!
May 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA, GSK, Novartis, Pfizer, environment, opioids, pharma, pricing
The pharmaceutical industry is a big polluter than the automotive industry. This was our top story this week. The findings …
China approves GSK’s shingles vaccine Shingrix
May 24, 2019Medical Communications, Sales and Marketing China, GSK, Shingrix, pharma, shingles
GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …
Sandoz is first multinational to secure generic approval under new Chinese guidelines
May 20, 2019Sales and Marketing China, Novartis, Sandoz, generics, pharma, rosuvastatin
Sandoz has revealed that its generic statin rosuvastatin, known in its branded incarnation as Crestor, has been given approval in …
Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says
May 14, 2019Manufacturing and Production China, US, USTR, pharma, tariffs, trade
The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …
China introduces new laws to ensure steady supply of drugs
April 17, 2019Research and Development China, National Health Commission, laws, markets, pharma, regulation
China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …
Novartis’ Cosentyx approved in China for plaque psoriasis
April 2, 2019Manufacturing and Production, Sales and Marketing China, Cosentyx, Novartis, pharma, psoriasis
Novartis has revealed that its interleukin-17A (IL-17A) Cosentyx (secukinumab) has been authorised for use in China in the treatment of …
China approves Keytruda for non-small cell lung cancer
April 2, 2019Manufacturing and Production China, MSD, Merck and Co, USA, keytruda, lung cancer, pharma
US firm MSD has won approval for Keytruda in China. The cancer immunotherapy has thus become the first PD-1 inhibitor …
Venezuela relaunch pharmaceutical industry with Chinese and Russian backing
March 21, 2019Manufacturing and Production China, Maduro, Russia, USA, Venezuela, pharma
President Maduro has pledged to relaunch Venezuela’s pharmaceutical industry, as part of an effort to address shortages of medicines in …
Top Ten most popular articles on Pharmafile.com this week!
March 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10
As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …
